Labs classified as BSL-4 are being built all around the world, many in countries with a history of poor controls and oversight of research practices.
We were at an inflection point with the COVID pandemic, between old and new tech, science institutions, policy, more. So what can we learn from past for future?
New economic research supports a shift from the pursuit of longevity at all costs to a focus on healthspan: more healthy time over the duration of one’s life.
As a new bio platforms becomes more broadly productive than ever before, it's even more important for startups to find platform, and partnership, fit.
It's easy to think extinction equals failure, but in fact, past life may encode the solutions to our most pressing future problems.
Which bio companies will have the greatest impact and scale? Which business models will endure the test of time? In short, those that "Compete or Connect"!
One possible solution to the replication crisis is to apply big data, "omics"-like approaches to the scientific literature: aka Publomics.
AI can revolutionize healthcare and the life sciences. But the reality, in practice, is that the potential of AI will be limited — unless it gets a lot smarter.
To harness the untapped power of subtraction in the future, we need to understand why we haven’t embraced it in the past.